Download - WHOCC
Download - WHOCC
Download - WHOCC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
QC03C<br />
HIGH-CEILING DIURETICS<br />
High-ceiling diuretics (loop-diuretics), e.g. furosemide, should be classified in<br />
this group.<br />
Combinations with potassium-sparing agents, see QC03EB.<br />
QC03CA<br />
QC03CB<br />
Sulfonamides, plain<br />
Sulfonamides and potassium in combination<br />
The 5th levels correspond to those in QC03CA - Sulfonamides, plain. See<br />
example in QC03AB.<br />
QC03CC<br />
QC03CD<br />
QC03CX<br />
Aryloxyacetic acid derivatives<br />
Pyrazolone derivatives<br />
Other high-ceiling diuretics<br />
All high-ceiling diuretics, which cannot be classified in the preceding groups,<br />
should be assigned to this group.<br />
QC03D<br />
QC03DA<br />
QC03DB<br />
POTASSIUM-SPARING AGENTS<br />
Aldosterone antagonists<br />
Other potassium-sparing agents<br />
QC03E<br />
QC03EA<br />
QC03EB<br />
DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION<br />
Low-ceiling diuretics and potassium-sparing agents<br />
High-ceiling diuretics and potassium-sparing agents<br />
QC03X<br />
QC03XA<br />
OTHER DIURETICS<br />
Vasopressin antagonists<br />
QC04<br />
QC04A<br />
PERIPHERAL VASODILATORS<br />
PERIPHERAL VASODILATORS<br />
Plain and combined preparations used in the treatment of cerebrovascular or<br />
peripheral circulatory disorders should be classified in this group.<br />
53
Change language